Effects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers

April 7, 2026 updated by: Chung-Ying Lin, National Cheng Kung University

Effects of Jing Si Herbal Tea on Quality of Life and Sleep Among Patients With Dementia and Their Caregivers: A Randomized Controlled Trial

Jing Si Herbal Tea has been found to be effective in improving health for the conditions of cancers, aging, depression, and sleep. Such evidence has been shown in animal models and clinical research with publications in the international journals. However, empirical evidence regarding the effectiveness of Jing Si Herbal Tea for patients with dementia and their caregivers on their quality of life and psychosocial health remains unclear. Therefore, the present project aims to investigate the feasibility of taking Jing Si Herbal Tea among patients with dementia; then, to investigate if Jing Si Herbal Tea could improve quality of life and psychosocial health for patients with dementia and their caregivers. The project will be three years. The first year will examine the feasibility for the patients with dementia. A total of 100 patients with dementia will be recruited and they will be informed to take the Jing Si Herbal Tea two times per day (one time in the morning and another time in the afternoon). All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to have initial evidence of the improvements in quality of life and psychosocial health without having a control group. The second year will recruit 200 patients with dementia and randomly assign them into a treatment group (taking Jing Si Herbal Tea) and a control group (taking placebo). All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to investigate the strong evidence of Jing Si Herbal Tea on quality of life and psychosocial health. The third year will recruit 200 caregivers of patient with dementia and randomly assign them into a treatment group (taking Jing Si Herbal Tea) and a control group (taking placebo). All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to investigate the strong evidence of Jing Si Herbal Tea on quality of life and psychosocial health.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Estimated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hualien City, Taiwan
        • Recruiting
        • Tzu-Chi General Hospital
        • Contact:
          • Hao-Ming Li, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

For people with dementia:

Inclusion Criteria:

  • diagnosis of dementia
  • 50 years or older
  • with sufficient cognition to complete the questionnaires
  • can communicate using Mandarin or Taiwanese

Exclusion Criteria:

  • with renal function problems
  • not suitable for Jing Si Herbal Tea after evaluation from a psychiatrist/physician
  • with the condition of change the commencement of guardianship (or commencement of assistance)

For caregivers:

Inclusion Criteria:

  • caregivers of people with dementia for more than half years
  • 20 years or older
  • with sufficient cognition to complete the questionnaires
  • can communicate using Mandarin or Taiwanese

Exclusion Criteria:

  • with renal function problems
  • not suitable for Jing Si Herbal Tea after evaluation from a psychiatrist/physician
  • with the condition of change the commencement of guardianship (or commencement of assistance)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Jing Si Herbal Tea Group
Frequency: Two times of herbal tea (one in the morning; one in the afternoon) per day Duration: Consumption for three months Dosage: One pack (14g) with 600 ml water for each time of herbal tea consumption
Consuming Jing Si Herbal Tea for three months; twice per day with each time 14 g of Jing Si Herbal in 600 ml water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
World Health Organization Quality of Life Assessment for age (WHOQOL-AGE) [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
quality of life measure; score range 13-65; higher score indicates better quality of life
baseline; 3 months after baseline; 6 months after baseline
Insomnia Severity Index [for both people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
sleep problem measure; score range 0-28; higher score indicates more severe insomnia
baseline; 3 months after baseline; 6 months after baseline
World Health Organization Quality of Life Assessment brief version (WHOQOL-BREF) [for caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
quality of life measure; score range 4-20; higher score indicates better quality of life
baseline; 3 months after baseline; 6 months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Katz Index of Independence in Activities of Daily Living [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
activities of daily living function measure; score range 0-6; higher score indicates better activities of daily living
baseline; 3 months after baseline; 6 months after baseline
5 items of Geriatric Depression Scale [for people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
depression measure; score range 0-5; higher score indicates greater depression
baseline; 3 months after baseline; 6 months after baseline
Short Portable Mental Status Questionnaire [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
cognition measure; score range 0-10; higher score indicates poor cognition
baseline; 3 months after baseline; 6 months after baseline
Clinical Frailty Scale [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
frailty measure; score range 1-9; higher score indicates more frail
baseline; 3 months after baseline; 6 months after baseline
Integrated care for older people [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
intrinsic capacity measure; score range 0-13; higher score indicates poorer intrinsic capacity
baseline; 3 months after baseline; 6 months after baseline
Attitude and Thoughts Toward Older People Scale [for people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
ageism measure; score range 17-85; higher score indicates higher level of ageism
baseline; 3 months after baseline; 6 months after baseline
Depression, Anxiety, Stress Scale-21 [for people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
psychological distress measure; score range 0-63; higher score indicates greater distress
baseline; 3 months after baseline; 6 months after baseline
12 item of Zarit Burden Interview [for caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
caregiver burden measure; score range 0-48; higher score indicates greater burden
baseline; 3 months after baseline; 6 months after baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comorbidity
Time Frame: baseline
Other chronic disease the participants have
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hao-Ming Li, MD, Buddhist Tzu Chi General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

December 27, 2023

First Submitted That Met QC Criteria

December 27, 2023

First Posted (Actual)

January 10, 2024

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 7, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Jing Si Herbal Tea

Subscribe